First-Year and Senior Students: Take the NSSE Survey and You Might Win a $25 Visa Gift Card
University of Cincinnati first-year students and seniors annually participate in the NSSE (National Survey of Student Engagement) to give the university a grade when it comes to programs, services to students, the student experience and more.
For instance, during last years 2015 survey collection,
that they have many more opportunities to gain real-world experiences than students at many other universities.
First-year students and seniors: you have received e-mails from President Santa Ono with your unique identifier and encouraging you to take the survey.
By taking the survey, you will be eligible to win a $25 Visa Gift Card from UCs Office of Institutional Research.
Fifty such $25 gift cards will be given away in random drawings of survey respondents.
Students who have already won gift cards are
- Nursing student Kelly Cole
- A&S student Elizabeth Crase
- A&S student Olivia Cunningham
- CEAS student Zachary Harp
- Nursing student Lauren Hawkins
- A&S student Melanie Jeffries
- CCM student Jody Jones
- A&S student Lindsey Massa
- A&S student Michael Peschka
- CEAS student George Reichert
- A&S student Carolyn Serbinski
- LCOB student Forest Wilson
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.